z-360 and Neuroendocrine-Tumors

z-360 has been researched along with Neuroendocrine-Tumors* in 1 studies

Reviews

1 review(s) available for z-360 and Neuroendocrine-Tumors

Article	Year
Potential clinical indications for a CCK Current opinion in pharmacology, 2016, Volume: 31 Gastrin controls gastric acid secretion and mucosal cell growth, especially of enterochromaffin-like cells, via gastrin/cholecystokinin-2 receptor (CCK Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Disease Models, Animal; Drug Design; Gastric Acid; Gastrins; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Phenylurea Compounds; Receptor, Cholecystokinin B; Stomach Neoplasms	2016

Article

Year

Potential clinical indications for a CCK

Current opinion in pharmacology, 2016, Volume: 31

Gastrin controls gastric acid secretion and mucosal cell growth, especially of enterochromaffin-like cells, via gastrin/cholecystokinin-2 receptor (CCK

Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Disease Models, Animal; Drug Design; Gastric Acid; Gastrins; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Phenylurea Compounds; Receptor, Cholecystokinin B; Stomach Neoplasms

2016